The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,614.00
Bid: 2,620.00
Ask: 2,622.00
Change: -22.00 (-0.83%)
Spread: 2.00 (0.076%)
Open: 2,640.00
High: 2,644.00
Low: 2,614.00
Prev. Close: 2,636.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

18 Jun 2019 16:30

RNS Number : 6664C
Coca-Cola HBC AG
18 June 2019
 

 

FOR IMMEDIATE RELEASE

Coca-Cola HBC AG

Results of Annual General Meeting of Coca-Cola HBC AG and election of Mr. Alfredo Rivera as a new Member of the Board of Directors

 

 

Zug, Switzerland - 18 June 2019 - Coca-Cola HBC AG ("Coca-Cola HBC") today announces that all of the proposals of the Board of Directors (the "Board") set out in the notice of the annual general meeting ("AGM") dated 14 May 2019 were duly passed by the requisite majority of shareholders at its AGM held today, 18 June 2019. The final results are set out below. A copy of the resolutions passed at the AGM has also been submitted to the National Storage Mechanism and will shortly be available for inspection at http://www.morningstar.co.uk/uk/NSM and on Coca-Cola HBC's website at www.coca-colahellenic.com 

 

Coca-Cola HBC's shareholders elected Mr. Alfredo Rivera as a new member of the Board. His biography can be found at www.coca-colahellenic.com

 

The AGM approved (i) a dividend of EUR 0.57 per share ("Ordinary Dividend") and (ii) a special dividend of EUR 2.00 per share ("Special Dividend") out of the general capital contribution reserve, capped at an amount of CHF 1,200,000,000. Payment of the full amount of Ordinary Dividend and the Special Dividend will be paid on 30 July 2019 to holders of ordinary shares on the record date of 5 July 2019. The shares are expected to be traded ex-dividend as of 4 July 2019, in which case the last day on which the shares may be traded with the entitlement to receive dividends will be 3 July 2019. In addition, the AGM approved a reduction in share capital by cancelling 3,249,803 registered shares held in treasury.

 

Final Ballot Results

 

Proposal

Votes

for

%

(1)

Votes Against

%

(1)

Abs-

tentions Cast

%

(1)

Total Votes Cast

Votes not cast (2)

Voting Rights Repre-

sented % (3)

1.

Receipt of the 2018 Integrated Annual Report, as well as approval of the annual management report, the stand-alone financial statements and the consolidated financial statements

234039707

99.91%

0

0.00%

206534

0.09%

234246241

0

64.55%

2.1.

Appropriation of available earnings

234122536

99.94%

114599

0.05%

9106

0.01%

234246241

0

64.55%

2.2.

Declaration of dividends from reserves

234188817

99.97%

48318

0.02%

9106

0.01%

234246241

0

64.55%

3.

Discharge of the members of the Board of Directors and the members of the Operating Committee

233255028

99.68%

528116

0.23%

208440

0.09%

233991584

0

64.48%

4.1.1.

Re-election of Anastassis G. David as a member of the Board of Directors and as the Chairman of the Board of Directors

(in a single vote)

224610663

95.88%

9625031

4.11%

10547

0.01%

234246241

0

64.55%

4.1.2.

Re-election of Alexandra Papalexopoulou as a member of the Board of Directors and as a member of the Remuneration Committee

(in a single vote)

233749626

99.78%

486068

0.21%

10547

0.01%

234246241

0

64.55%

4.1.3.

Re-election of Reto Francioni as a member of the Board of Directors and as a member of the Remuneration Committee

(in a single vote)

230977455

98.60%

3257917

1.39%

10869

0.01%

234246241

0

64.55%

4.1.4.

Re-election of Charlotte J. Boyle as a member of the Board of Directors and as a member of the Remuneration Committee

(in a single vote)

233798550

99.80%

436822

0.19%

10869

0.01%

234246241

0

64.55%

4.1.5.

Re-election of Zoran Bogdanovic as a member of the Board of Directors

232485911

99.24%

1751256

0.75%

9074

0.01%

234246241

0

64.55%

4.1.6.

Re-election of Olusola (Sola) David-Borha as a member of the Board of Directors

233743656

99.78%

491716

0.21%

10869

0.01%

234246241

0

64.55%

4.1.7.

Re-election of William W. Douglas III as a member of the Board of Directors

232510310

99.25%

1725062

0.74%

10869

0.01%

234246241

0

64.55%

4.1.8.

Re-election of Anastasios I. Leventis as a member of the Board of Directors

224089173

95.66%

10146521

4.33%

10547

0.01%

234246241

0

64.55%

4.1.9.

Re-election of Christodoulos Leventis as a member of the Board of Directors

224353352

95.77%

9882342

4.22%

10547

0.01%

234246241

0

64.55%

4.1.10.

Re-election of José Octavio Reyes as a member of the Board of Directors

224353020

95.77%

9882352

4.22%

10869

0.01%

234246241

0

64.55%

4.1.11.

Re-election of Ryan Rudolph as a member of the Board of Directors

224105121

95.67%

10130251

4.32%

10869

0.01%

234246241

0

64.55%

4.1.12.

Re-election of John P. Sechi as a member of the Board of Directors

232965748

99.45%

1269624

0.54%

10869

0.01%

234246241

0

64.55%

4.2.

Election of Alfredo Rivera as a new member of the Board of Directors

224255808

95.73%

9979725

4.26%

10708

0.01%

234246241

0

64.55%

5.

Election of the independent proxy

234237135

99.99%

0

0.00%

9106

0.01%

234246241

0

64.55%

6.1.

Re-election of the statutory auditor

233405058

99.64%

830636

0.35%

10547

0.01%

234246241

0

64.55%

6.2.

Advisory vote on re-appointment of the independent registered public accounting firm for UK purposes

233404812

99.64%

830542

0.35%

10887

0.01%

234246241

0

64.55%

7.

Advisory vote on the UK Remuneration Report

232487763

99.24%

1747581

0.75%

10897

0.01%

234246241

0

64.55%

8.

Advisory vote on the Remuneration Policy

224790736

95.96%

9445934

4.03%

9571

0.01%

234246241

0

64.55%

9.

Advisory vote on the Swiss Remuneration Report

232323962

99.17%

1911392

0.82%

10887

0.01%

234246241

0

64.55%

10.1.

Approval of the maximum aggregate amount of remuneration for the Board of Directors until the next annual general meeting

232930428

99.44%

1304801

0.56%

11012

n.a.

234235229

0

64.55%

10.2.

Approval of the maximum aggregate amount of remuneration for the Operating Committee for the next financial year

231596412

98.98%

2385368

1.02%

264461

n.a.

233981780

0

64.55%

11.

Approval of a share capital reduction by cancelling treasury shares

234235185

99.98%

1451

0.01%

9605

0.01%

234246241

0

(0.00%)

64.55%

 

(1) Percentages refer to applicable majority. Proposals 1-9 require approval by an absolute majority of the votes validly cast (including consenting and dissenting votes and abstentions). Proposals 10.1 and 10.2 require approval by a relative majority of the votes validly cast (including consenting and dissenting votes without abstentions). Proposal 11 requires approval by a majority of at least two-thirds of the voting rights represented and an absolute majority of the nominal value of shares represented.

 

(2) Votes represented at the AGM but not (or not validly) cast.

 

(3) Shares represented at the AGM for each proposal as a percentage of Coca-Cola HBC's outstanding voting rights, whether exercisable or not. As at the date of the AGM, Coca-Cola HBC's issued share capital consisted of 372,801,582 ordinary shares, of which 6,477,901 ordinary shares are held by Coca-Cola HBC AG and 3,430,135 shares are held by its subsidiary, COCA-COLA HBC SERVICES MEPE, in treasury. Accordingly, the total number of outstanding voting rights (whether exercisable or not) in Coca-Cola HBC AG was 362,893,546.

 

 

 

 

Enquiries

Coca‑Cola HBC Group

 

 

Joanna Kennedy

Investor Relations Director

Tel: +44 20 37 444 230

 joanna.kennedy@cchellenic.com

 

 

Carla Fabiano

Investor Relations Manager

Tel: +44 20 37 444 231

carla.fabiano@cchellenic.com

 

Sofia Grigoratou

Investor Relations Manager

Tel: +30 210 618 3327

 sofia.grigoratou@cchellenic.com

 

 

 

About Coca‑Cola HBC

Coca-Cola HBC is a leading bottler of The Coca-Cola Company with an annual sales volume of more than 2 billion unit cases. It has a broad geographic footprint with operations in 28 countries serving a population of more than 600 million people. Coca-Cola HBC offers a diverse range of primarily non-alcoholic ready-to-drink beverages in the sparkling, juice, water, sport, energy, tea and coffee categories. Coca-Cola HBC is committed to promoting sustainable development in order to create value for its business and for society. This includes providing products that meet the beverage needs of consumers, fostering an open and inclusive work environment, conducting its business in ways that protect and preserve the environment and contribute to the socio-economic development of the local communities. Coca-Cola HBC is ranked among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG and FTSE4Good, among others.

 

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and its shares are listed on the Athens Exchange (ATHEX: EEE). For more information, please visit http://www.coca-colahellenic.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGEASKPFAPNEFF
Date   Source Headline
3rd May 20245:25 pmRNSTransaction in Own Shares
3rd May 202412:46 pmRNSDirector/PDMR Shareholding
3rd May 202412:38 pmRNSDirector/PDMR Shareholding
2nd May 20245:41 pmRNSTransaction in Own Shares
2nd May 202412:40 pmRNSAthens Exchange trading date of ordinary shares
1st May 20245:47 pmRNSTransaction in Own Shares
1st May 202410:09 amRNSBlock listing Interim Review
1st May 20249:10 amRNSIssue of equity and total voting rights
30th Apr 20247:00 amRNSStrong start; reiterating 2024 guidance
19th Apr 20249:20 amRNSNotice of AGM
18th Apr 20244:21 pmRNSDirector/PDMR Shareholding
5th Apr 20242:17 pmRNSNotice of Results
2nd Apr 202411:12 amRNSIssue of equity and total voting rights
28th Mar 20245:55 pmRNSDirector/PDMR Shareholding
28th Mar 20245:47 pmRNSDirector/PDMR Shareholding
28th Mar 20245:42 pmRNSDirector/PDMR Shareholding
28th Mar 20245:26 pmRNSTransaction in Own Shares
27th Mar 20245:23 pmRNSTransaction in Own Shares
26th Mar 20245:05 pmRNSTransaction in Own Shares
26th Mar 20249:09 amRNSDirector/PDMR Shareholding
25th Mar 20245:10 pmRNSTransaction in Own Shares
22nd Mar 20245:27 pmRNSTransaction in Own Shares - Replacement
22nd Mar 20245:05 pmRNSTransaction in Own Shares
21st Mar 20245:40 pmRNSTransaction in Own Shares
20th Mar 20245:33 pmRNSTransaction in Own Shares
19th Mar 20245:20 pmRNSTransaction in Own Shares
19th Mar 20241:19 pmRNSDirector/PDMR Shareholding
18th Mar 20245:20 pmRNSTransaction in Own Shares
15th Mar 20246:25 pmRNSTransaction in Own Shares
15th Mar 20245:58 pmRNSAnnual Financial Report
14th Mar 20245:30 pmRNSTransaction in Own Shares
14th Mar 20243:04 pmRNSDirector/PDMR Shareholding
14th Mar 20242:56 pmRNSDirector/PDMR Shareholding
13th Mar 20245:20 pmRNSTransaction in Own Shares
12th Mar 20245:15 pmRNSTransaction in Own Shares
11th Mar 20245:50 pmRNSTransaction in Own Shares
8th Mar 20245:45 pmRNSTransaction in Own Shares
7th Mar 20245:20 pmRNSTransaction in Own Shares
6th Mar 20245:10 pmRNSTransaction in Own Shares
5th Mar 20245:15 pmRNSTransaction in Own Shares
4th Mar 20245:55 pmRNSTransaction in Own Shares
1st Mar 20245:15 pmRNSTransaction in Own Shares
1st Mar 20249:25 amRNSIssue of Equity and total voting rights
29th Feb 20245:25 pmRNSTransaction in Own Shares
29th Feb 20243:10 pmRNSDirector/PDMR Shareholding
29th Feb 20243:00 pmRNSDirector/PDMR Shareholding
29th Feb 20242:53 pmRNSDirector/PDMR Shareholding
28th Feb 20245:25 pmRNSTransaction in Own Shares
27th Feb 20245:35 pmRNSTransaction in Own Shares
26th Feb 20245:35 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.